Source: Medical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS (CIRURGIA;CONSERVAÇÃO), QUIMIOTERAPIA ADJUVANTE
ABNT
ANDRADE, J. M. et al. Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer. Medical Oncology, v. 28, p. s65-s69, 2011Tradução . . Disponível em: https://doi.org/10.1007/s12032-010-9711-0. Acesso em: 10 jun. 2024.APA
Andrade, J. M., Carrara, H. H. A., Pimentel, F. F., Marana, H. R. C., Macchetti, A. H., Mouro, L. R., et al. (2011). Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer. Medical Oncology, 28, s65-s69. doi:10.1007/s12032-010-9711-0NLM
Andrade JM, Carrara HHA, Pimentel FF, Marana HRC, Macchetti AH, Mouro LR, Zola FE, Tiezzi DG. Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer [Internet]. Medical Oncology. 2011 ; 28 s65-s69.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s12032-010-9711-0Vancouver
Andrade JM, Carrara HHA, Pimentel FF, Marana HRC, Macchetti AH, Mouro LR, Zola FE, Tiezzi DG. Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer [Internet]. Medical Oncology. 2011 ; 28 s65-s69.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s12032-010-9711-0